Volagidemab (Anti-GCGR)

Volagidemab (Anti-GCGR) is an antagonistic monoclonal antibody (mAb) that targets glucagon receptor (GCGR). Volagidemab can be used in the research of type 1 diabetes (T1D). MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2487
Sku # A2487-1mg*25
Pricing 1mg*25, $5070.00
Feedback